Table 3.
Levels of Blood Lipids and Correlated Indexes by Gene Polymorphism Between Case and Control Subjects
| Case | Control | |||
|---|---|---|---|---|
| CC+CT | TT | CC+CT | TT | |
| HCY (μM) | 26.58±8.36 | 29.69±7.75 | 16.48±7.79 | 22.41±14.61 |
| Lp (a) (g/L) | 31.55±19.12 | 42.50±19.22 | 18.78±14.99 | 24.00±21.53 |
| HDL (mM) | 0.98±0.22 | 1.01±0.24 | 0.99±0.23 | 0.98±0.23 |
| LDL (mM) | 2.81±0.77 | 2.91±0.86 | 2.65±0.76 | 2.83±0.92 |
| Apo AI (g/L) | 1.05±0.17 | 1.09±0.20 | 1.00±0.28 | 0.99±0.20 |
| Apo B (g/L) | 0.76±0.18 | 0.79±0.21 | 0.81±0.23 | 0.83±0.21 |
| GLU (mM) | 5.39±1.29 | 5.45±1.50 | 5.30±1.77 | 5.35±1.92 |
| TC (mM) | 4.39±0.99 | 4.50±1.13 | 4.39±0.95 | 4.57±1.14 |
| TG (mM) | 1.68±1.24 | 1.73±1.55 | 1.55±0.85 | 1.55±0.79 |
HCY and Lp (a) levels in those with the TT genotype were significantly higher than in those with the CC/CT genotype, regardless of whether they were case or control subjects. HCY: p<0.001, Lp (a): control, p=0.005; hypertensive, p=0.003.